Pre-market · Oct 6, 4:10 am ET · After hours $29.51 0.00%
Open$29.38
Prev close$29.37
Day range$29.24 – $29.91
Volume439.7K
Market cap$1.93B
P/E (TTM)2.9
Dividend yield–
LKFT Stock News
Headlines matching Lakefront Biotherapeutics or the LKFT ticker, most recent first.
RBC Capital Upgrades Lakefront Biotherapeutics(LKFT.US) to Buy Rating, Raises Target Price to $45Market news · 23 Sep 2026
Morgan Stanley Upgrades Lakefront Biotherapeutics(LKFT.US) to Hold Rating, Raises Target Price to $30Market news · 3 Aug 2026
Morgan Stanley Maintains Lakefront Biotherapeutics(LKFT.US) With Hold Rating, Maintains Target Price $30Market news · 10 Aug 2026
Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR)TipRanks · 10 Aug 2026
RBC Capital Initiates Lakefront Biotherapeutics(LKFT.US) With Hold Rating, Announces Target Price $28Market news · 13 May 2026
Discussion
No comments yet — be the first to weigh in on LKFT.
No comments yet — be the first to weigh in on LKFT.